Tissue regulatory T cells (Tregs) exert pivotal functions in both immune and metabolic regulation, maintaining local tissue homeostasis, integrity, and function. Accordingly, Tregs play a crucial role in controlling obesity-induced inflammation and supporting efficient muscle function and repair. Depending on the tissue context, Tregs are characterized by unique transcriptomes, growth, and survival factors and T cell receptor (TCR) repertoires. This functional specialization offers the potential to selectively target context-specific Treg populations, tailoring therapeutic strategies to specific niches, thereby minimizing potential side effects. Here, we discuss challenges and perspectives for niche-specific Treg targeting, which holds promise for highly efficient and precise medical interventions to combat metabolic disease.
Publishing Place50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
University
University place
Faculty
Publication date0000-00-00
Application number
Application date0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing statusPeer reviewed
Institute(s)Research Unit Type 1 Diabetes Immunology (TDI)
GrantsDeutsche Forschungsgemeinschaft (DFG, German Research Foundation) Ludwig-Maximilians-Universitat Munchen German Center for Diabetes Research (DZD) Helmholtz Munich Innovation and Translation Fund 2023 EFSD/JDRF/Lilly Program on Type 1 Diabetes Research 2020 Research Group at Helmholtz Zentrum Munchen of the Deutsche Forschungsgemeinschaft Excellence Program for Outstanding Female Scientists from the Helmholtz Association